Last reviewed · How we verify
NCT03299205: ALIVE-Ex
Alcohol & Metabolic Comorbidities in PLWHA: Evidence Driven Interventions
NA trial testing Exercise in HIV/AIDS in 68 participants. Completed in 15 September 2023.
15 September 2023
Quick facts
| Lead sponsor | Louisiana State University Health Sciences Center in New Orleans |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 68 |
| Start date | 20 November 2017 |
| Primary completion | 15 September 2023 |
| Estimated completion | 15 September 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Exercise
Conditions studied
- HIV/AIDS — all drugs for HIV/AIDS →
- Dysglycemia — all drugs for Dysglycemia →
- Alcohol Use Disorder — all drugs for Alcohol Use Disorder →
Sponsor
Louisiana State University Health Sciences Center in New Orleans
Who can join
18 and older, any sex, with HIV/AIDS or Dysglycemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cross-sectional and prospective studies are proposed to test the prediction that a higher proportion of HIV+ individuals with hazardous alcohol drinking with subclinical fasting dysglycemia will present with impaired oral glucose tolerance and dysfunctional metabolic skeletal muscle phenotype. Prospective studies will test the efficacy of an exercise intervention in improving glycemic control. Results will inform larger scale interventions to ameliorate metabolic comorbidities, improve health, quality of life, and possibly decrease hazardous alcohol drinking.
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
Skeletal muscle bioenergetic health and function in people living with HIV: association with glucose tolerance and alcohol use.
Levitt DE, Ferguson TF, Primeaux SD, Zavala JA, et al · · 2021 · cited 17× · PMID 34585616 · DOI 10.1152/ajpregu.00197.2021 -
Alcohol use and dysglycemia among people living with human immunodeficiency virus (HIV) in the Alcohol & Metabolic Comorbidities in PLWH: Evidence Driven Interventions (ALIVE-Ex) study.
Primeaux SD, Simon L, Ferguson TF, Levitt DE, et al · · 2021 · cited 9× · PMID 34342022 · DOI 10.1111/acer.14667 -
Unique circulating microRNA associations with dysglycemia in people living with HIV and alcohol use.
Bourgeois BL, Lin HY, Yeh AY, Levitt DE, et al · · 2022 · cited 5× · PMID 34859690 · DOI 10.1152/physiolgenomics.00085.2021 -
An aerobic exercise intervention to improve metabolic health among people living with HIV with at-risk alcohol use: the ALIVE-Ex research study protocol.
Simon L, Primeaux SD, Levitt DE, Bourgeois B, et al · · 2023 · cited 2× · PMID 37296413 · DOI 10.1186/s12981-023-00530-2 -
Alcohol misuse and health-related behaviors among people with HIV during the COVID-19 stay-at-home directive: an ALIVE-Ex sub-study.
Ferguson TF, Levitt DE, Simon L, Molina PE, et al · · 2025 · PMID 40267314 · DOI 10.1093/alcalc/agaf019
Verify or expand the search:
- PubMed search for NCT03299205
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Exercise
Trials testing the same drug.
- NCT06231069 — Mixed Exercise Training and Novel Multi-Nutrient Supplementation in Young Adults · NA · withdrawn
- NCT07007858 — Effects of High-Velocity Passive Stretch on Spasticity, Function, and Muscle Structure in Spastic CP Children · NA · enrolling by invitation
- NCT07589725 — Mulligan Mobilization in Lateral Elbow Tendinopathy · NA · not yet recruiting
- NCT07524400 — Effects of Physical Exercise Combined With Transcranial Direct Current Stimulation in Parkinson's Disease · NA · recruiting
- NCT06627569 — Exercise Effects on the Neurobiology Underlying Stress-related Eating Behaviors in Veterans · NA · not yet recruiting
Other recruiting trials for HIV/AIDS
Currently open trials in the same condition.
- NCT06741618 — MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM · NA · recruiting
- NCT07298785 — Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Pilot Study · NA · recruiting
- NCT07072481 — Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing · NA · recruiting
- NCT07064785 — Video-Intervention to Inspire Treatment Adherence for Life for Adolescents · NA · recruiting
- NCT07074899 — Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in Peru · NA · active not recruiting
Other Louisiana State University Health Sciences Center in New Orleans trials
Trials by the same sponsor.
- NCT07462767 — Precision Microbiota Interventions for Senoreduction Trial · Phase 1, PHASE2 · not yet recruiting
- NCT07488156 — Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder · NA · not yet recruiting
- NCT07280260 — Clinical Performance of Nobel N1 System · Phase 4 · recruiting
- NCT06773715 — Virtual Reality As Adjunct Therapy for Vaso-Occlusive Pain · NA · recruiting
- NCT06874244 — Clinical Evaluation of no Needle Dental Anesthesia Compared to Syringe Anesthesia Delivery · EARLY_PHASE1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03299205 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Louisiana State University Health Sciences Center in New Orleans
- Last refreshed: 3 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03299205.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing